Association of Psychological Distress in Patients With Lung Cancer

Last updated: May 20, 2025
Sponsor: Shanghai Chest Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer Treatment

Cancer

Chemotherapy

Treatment

Targeted Therapy Agent

immunotherapy

Clinical Study ID

NCT06218901
THORACIC005
  • Ages > 18
  • All Genders

Study Summary

Psychological distress is a multi-factorial experience of a psychological, social, spiritual, and/or physical nature that may interfere with one's ability to cope effectively with cancer, physical symptoms and treatment. Psychological distress is common and affects the efficacy and prognosis of patients with lung cancer. The systematic anti-tumor therapy may effectively relieve psychological distress including anxiety, depression, and fatigue in patients with advanced lung cancer, the relief of the psychological distress can in turn improve the therapeutic effect.

In summary, this study is to explore the associations of (dynamic) psychological stress with the efficacy and survival of anti-tumor therapy including immunotherapy and targeted therapy for advanced lung cancer patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Histologically proven diagnosis of lung cancer

  • 18 years of age or older

  • Ability to understand and the willingness to sign a written informed consentdocument

Exclusion

Exclusion Criteria:

  • Not willing to participate in this clinical trial

Study Design

Total Participants: 500
Treatment Group(s): 2
Primary Treatment: Targeted Therapy Agent
Phase:
Study Start date:
January 01, 2016
Estimated Completion Date:
December 31, 2028

Connect with a study center

  • Shanghai Chest Hospital

    Shanghai, Shanghai 200030
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.